nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing the benefits of lipid-lowering therapy
|
Gotto Jr., Antonio M. |
|
1998 |
82 |
6S1 |
p. 2M-4M nvt p. |
artikel |
2 |
Clinical trial endpoints: angiograms, events, and plaque instability
|
Ballantyne, Christie M. |
|
1998 |
82 |
6S1 |
p. 5M-11M nvt p. |
artikel |
3 |
Coronary arteriography and lipid lowering: limitations, new concepts, and new paradigms in cardiovascular medicine
|
Gould, K.Lance |
|
1998 |
82 |
6S1 |
p. 12M-21M nvt p. |
artikel |
4 |
Economic implications of lipid-lowering trials: current considerations in selecting a statin
|
Farmer, John A. |
|
1998 |
82 |
6S1 |
p. 26M-31M nvt p. |
artikel |
5 |
Future of lipid-lowering trials: what else do we need to know?
|
Jones, Peter H. |
|
1998 |
82 |
6S1 |
p. 32M-38M nvt p. |
artikel |
6 |
Introduction
|
Gotto Jr., Antonio M. |
|
1998 |
82 |
6S1 |
p. 1M- 1 p. |
artikel |
7 |
Relation of clinical benefit to metabolic effects in lipid-lowering therapy
|
Herd, J.Alan |
|
1998 |
82 |
6S1 |
p. 22M-25M nvt p. |
artikel |